Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | S100P |
| Upstream (Parents) |
|---|
| (<<) ALDOA → S100P |
| (<<) ASNS → S100P |
| (<<) B3GNT3 → S100P |
| (<<) DDR1 → S100P |
| (<<) ELF3 → S100P |
| (<<) MTHFD2 → S100P |
| (<<) PRSS3 → S100P |
| Downstream (Children) |
|---|
| S100P → ADAM15 (>>) |
| S100P → ATP10B (>>) |
| S100P → CCNE1 (>>) |
| S100P → CDCP1 (>>) |
| S100P → CREB3L1 (>>) |
| S100P → CSNK1E (>>) |
| S100P → CSTB (>>) |
| S100P → CXCL3 (>>) |
| S100P → DPH2 (>>) |
| S100P → E2F2 (>>) |
| S100P → ELOVL1 (>>) |
| S100P → EPN3 (>>) |
| S100P → EVX1 (>>) |
| S100P → FA2H (>>) |
| S100P → FUT4 (>>) |
| S100P → GNG5 (>>) |
| S100P → ITGA3 (>>) |
| S100P → ITGB4 (>>) |
| S100P → ITGB6 (>>) |
| S100P → KCNK1 (>>) |
| S100P → KLK10 (>>) |
| S100P → LGALS3 (>>) |
| S100P → NBL1 (>>) |
| S100P → PABPC3 (>>) |
| S100P → PCSK7 (>>) |
| S100P → PHLDA2 (>>) |
| S100P → PI3 (>>) |
| S100P → PIK3R1 (>>) |
| S100P → PLEK2 (>>) |
| S100P → PRKCD (>>) |
| S100P → PRR7 (>>) |
| S100P → RHOA (>>) |
| S100P → SERPINB1 (>>) |
| S100P → SFN (>>) |
| S100P → STK17B (>>) |
| S100P → TAGLN2 (>>) |
| S100P → TFF1 (>>) |
| S100P → TK1 (>>) |
| S100P → TSPO (>>) |
| S100P → TUBB2C (>>) |
| S100P → VANGL1 (>>) |
| S100P → VPS37B (>>) |
